ABCC9
ATP-binding cassette sub-family C member 9
As of the edition of 20 October 2026, ABCC9 (ATP-binding cassette sub-family C member 9, UniProt O60706) has 2 drugs tested at it and 4 companies on the list, 0 on route A and 2 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- O60706
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- At a membrane
- Disease areas
- Skin and connective tissue; Cancer; Heart and blood vessels; Hormones; Inherited and neonatal; Nervous system; Pregnancy and women's health; Urinary and reproductive
- Registered trials of its drugs
- 45
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 2 |
| Total | 2 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Minoxidil | Marketed | Phase 4 | none listed |
| Pinacidil anhydrous | Marketed | No phase stated | none listed |
2 of 2 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route B | 2 |
| Engaged | 1 |
| Undetermined | 1 |
| Total on the list | 4 |
| Company | Route |
|---|---|
| Leo Pharmaceutical | Route B |
| Pfizer | Route B |
The other 2 companies at ABCC9
In the product4 companies in all; 2 are not named here, and no score is.
See the 4 companies at ABCC9, ranked, with the facts behind eachRequest access. Nothing is shown until you do.